Juniper Pharmaceuticals Inc - Company & Market Research Reports

Juniper Pharmaceuticals focuses on developing therapeutics that address unmet medical needs in women's health. The company develops its products using its drug delivery technologies and a novel intra-vaginal ring (IVR) technology. It markets Crinone, which is commercially available in the United States and over 90 countries around the world. Its current intravaginal ring (IVR) product candidates are JNP-0101, JNP-0201 and JNP-0301. Juniper Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Boston, Massachusetts.

From
From
From
From
Overactive Bladder - Pipeline Review, H1 2018 - Product Thumbnail Image

Overactive Bladder - Pipeline Review, H1 2018

  • Drug Pipelines
  • 110 Pages
From
From
From
From
From
Juniper Pharmaceuticals Inc - Product Thumbnail Image

Juniper Pharmaceuticals Inc

  • Company Profile
  • 69 Pages
Loading Indicator
adroll